Flow-S: A Field-Deployable Device with Minimal Hands-On Effort to Concentrate and Quantify Schistosoma Circulating Anodic Antigen (CAA) from Large Urine Volumes
Diagnostics · 16.04.2024 · 14 (8) · 820
DOI: 10.3390/diagnostics14080820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 16.04.2024. Verfasst von Daniëlle de Jong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, FIC NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
A laboratory-based lateral flow (LF) test that utilizes up-converting reporter particles (UCP) for ultrasensitive quantification of Schistosoma circulating anodic antigen (CAA) in urine is a well-accepted test to identify active infection. However, this UCP-LF CAA test requires sample pre-treatment steps not compatible with field applications. Flow, a new low-cost disposable, allows integration of large-volume pre-concentration of urine analytes and LF detection into a single field-deployable device. We assessed a prototype Flow-Schistosoma (Flow-S) device with an integrated UCP-LF CAA test strip, omitting all laboratory-based steps, to enable diagnosis of active Schistosoma infection in the field using urine. Flow-S is designed for large-volume (5–20 mL) urine, applying passive paper-based filtration and antibody-based CAA concentration. Samples tested for schistosome infection were collected from women of reproductive age living in a Tanzania region where S. haematobium infection is endemic. Fifteen negative and fifteen positive urine samples, selected based on CAA levels quantified in paired serum, were analyzed with the prototype Flow-S. The current Flow-S prototype, with an analytical lower detection limit of 1 pg CAA/mL, produced results correlated with the laboratory-based UCP-LF CAA test. Urine precipitates occurred in frozen banked samples and affected accurate quantification; however, this should not occur in fresh urine. Based on the findings of this study, Flow-S appears suitable to replace the urine pre-treatment required for the laboratory-based UCP-LF CAA test, thus allowing true field-based applications with fresh urine samples. The urine precipitates observed with frozen samples, though less important given the goal of testing fresh urines, warrant additional investigation to evaluate methods for mitigation. Flow-S devices permit testing of pooled urine samples with applications for population stratified testing. A field test with fresh urine samples, a further optimized Flow-S device, and larger statistical power has been scheduled.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cell and Chemical Biology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
- Salus Discovery LLC, Madison, WI 53703, USA.
- Mwanza Intervention Trials Unit/National Institute for Medical Research, Mwanza, Tanzania.
- Department of Parasitology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
- Division of Infectious Diseases, Weill Cornell Medicine, New York, NY 10065, USA.
- Center for Global Health, Weill Cornell Medicine, New York, NY 10065, USA.
ORCID-Profile: Daniëlle de Jong, Jay W Warrick, Paul L A M Corstjens
Förderung
- NIAID NIH HHS
- FIC NIH HHS
- NIBIB NIH HHS
- National Institute of Biomedical Imaging of the National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Fogarty International Center
Zitieren
APA
de Jong, D., Carrell, C., Maganga, J. K., Mhango, L., Shigella, P. S., Gill, M., Shogren, R., Mullins, B., Warrick, J. W., Changalucha, J. M., van Dam, G. J., Pham, K., Downs, J. A., & Corstjens, P. L. A. M. (2024). Flow-S: A Field-Deployable Device with Minimal Hands-On Effort to Concentrate and Quantify Schistosoma Circulating Anodic Antigen (CAA) from Large Urine Volumes. Diagnostics, 14(8), 820. https://doi.org/10.3390/diagnostics14080820
Vancouver
de Jong D, Carrell C, Maganga JK, Mhango L, Shigella PS, Gill M, et al. Flow-S: A Field-Deployable Device with Minimal Hands-On Effort to Concentrate and Quantify Schistosoma Circulating Anodic Antigen (CAA) from Large Urine Volumes. Diagnostics. 2024;14(8):820. doi:10.3390/diagnostics14080820
BibTeX
@article{deJong2024,
author = {de Jong, Daniëlle and Carrell, Cody and Maganga, Jane K and Mhango, Loyce and Shigella, Peter S and Gill, Maddy and Shogren, Ryan and Mullins, Brianna and Warrick, Jay W and Changalucha, John M and van Dam, Govert J and Pham, Khanh and Downs, Jennifer A and Corstjens, Paul L A M},
title = {Flow-S: A Field-Deployable Device with Minimal Hands-On Effort to Concentrate and Quantify Schistosoma Circulating Anodic Antigen (CAA) from Large Urine Volumes},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {8},
pages = {820},
doi = {10.3390/diagnostics14080820}
}
EUVIMED